Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia;Efecto de la dosis oral de hidrocortisona sobre la velocidad de crecimiento en niños con la forma perdedora de sodio de la hiperplasia suprarrenal congénita

Medicina

Volumn 62, Issue 6, 2002, Pages 551-554

  Ciaccio, Marta ^a   Montiveros, Carolina ^a   Rivarola, Marco A ^a   Belgorosky, Alicia ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Congenital adrenal hyperplasia; Growth rate under corticoids; Hydrocrotisone dose

Indexed keywords

ANDROGEN; ELECTROLYTE; FLUDROCORTISONE; HYDROCORTISONE; HYDROXYPROGESTERONE; RENIN;

AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; CALCULATION; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG MEGADOSE; ELECTROLYTE BALANCE; FEMALE; FOLLOW UP; GROWTH DISORDER; GROWTH RATE; HUMAN; INFANT; LONG TERM CARE; LONGITUDINAL STUDY; MALE; PREDICTION; SALT LOSING NEPHRITIS; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ADRENAL HYPERPLASIA, CONGENITAL; ANTI-INFLAMMATORY AGENTS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; INFANT; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; SODIUM CHLORIDE; TIME FACTORS;

EID: 0036954387     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Young MC, Hughes IA. Response to treatment of congenital adrenal hyperplasia in infancy. Arch Dis Child 1990; 65: 441-4.
2. Silva IN, Kater CE, Cunha CF, Viana MB. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia. Arch Dis Child 1997; 77: 217-8.
3. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-91.
4. Kenny FM, Preeyasomblat C, Migeon CJ. Cortisol production rate: II. Normal infants, children and adults. Pediatrics 1966; 37: 34-42.
5. Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol A. Estimation of daily cortisol production and clearance in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 1993; 76: 1505-10.
6. Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F. Cortisol production rate in childhood and adolescence. J Pediatr 1990; 117: 892-6.
7. Jaaskelainen J, Voutilainen R. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res 1997; 41: 30-3.
8. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist, ed 2, Standford CA: Stanford University Press, 1959.
9. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-41.
10. Dimartino-Nardi J, Stoner E, O'Connell A, New MI. The effect of treatment on final height in classical congenital adrenal hyperplasia. Acta Endocrinol 1986; 279 (suppl): 305-13.
11. Rappaport R, Cornu G, Royer P. Statural growth in congenital adrenal hyperplasia treated with hydrocortisone. J Pediatr 1968; 73: 60-766.
12. Young MC, Ribeiro J, Hughes IA. Growth and body proportions in congenital adrenal hyperplasia. Arch Dis Child 1989; 64: 1554-8.
13. Gussinye M, Potau N, Vicens-Calvet E, et al. Adult height, pattern of growth and pubertal development in patients with congenital adrenal hyperplasia, salt losing form. Med Clin 1997; 108: 87-90.
14. Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia J Clin Endocrinol Metab 2001; 86: 3070-8.
15. Quintos JB, Vogiatzi MG, Harbinson MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 1511-7.